Related Experiment Video
Updated: Oct 14, 2025
09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
30.4K
Anno 2021: Which antivirals for the coming decade?
Elisabetta Groaz1,2, Erik De Clercq3, Piet Herdewijn1
1Medicinal Chemistry, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Annual Reports in Medicinal Chemistry
|November 8, 2021
Summary
New antiviral drug development is crucial as many viral infections, including emerging and ancient diseases, lack effective treatments. Research is accelerating to combat threats like influenza, SARS-CoV-2, and viral hemorrhagic fevers.
Area of Science:
- Virology
- Infectious Diseases
- Drug Discovery
Background:
- Despite successes in antiviral therapies for HIV and HCV, numerous viral infections remain untreatable.
- Emerging zoonotic viruses (e.g., SARS-CoV-2), ancient vaccine-controlled diseases, and endemic respiratory infections pose significant public health challenges.
- Climate change and air pollution exacerbate the risk of viral diseases, including respiratory infections and hemorrhagic fevers.
Purpose of the Study:
- To review recent advancements in the development of novel antiviral therapies.
- To address the urgent need for effective treatments against a range of viral threats.
- To highlight the growing importance of antiviral research in the face of global health challenges.
Main Methods:
- Literature review of recent scientific publications on antiviral drug discovery.
- Analysis of current research trends and progress in combating various viral infections.
- Synthesis of information on emerging and re-emerging viral threats.
Main Results:
- Significant progress has been made in identifying potential antiviral candidates for various viral diseases.
- The study identifies key viral threats requiring urgent therapeutic intervention.
- The review underscores the increasing frequency and global impact of viral infections.
Conclusions:
- Continued research and development of new antivirals are essential to manage current and future viral threats.
- Antiviral strategies must address both emerging and persistent viral diseases.
- Global collaboration and investment are vital for effective antiviral drug discovery and deployment.
Related Concept Videos
01:29Subviral Agents
203
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
203
01:10Retrovirus Life Cycles
47.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.6K
02:33Retroviruses
12.9K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.9K
01:29Viruses with RNA Genomes
226
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
226
01:51Mechanisms of Retrovirus-induced Cancers
5.4K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.4K
00:36Viral Mutations
34.7K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
34.7K